Your search returned 387 results.

Results
	101.	Real-life rilpivirine resistance and potential emergence of an E138A-positive HIV strain in north-eastern France. [electronic resource] by Jeulin, H Foissac, M Boyer, L Agrinier, N Perrier, P Kennel, A Velay, A Goehringer, F Henard, S Rabaud, C May, T Schvoerer, E Producer: 20150622 In: The Journal of antimicrobial chemotherapy vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	102.	Nonnucleoside Reverse Transcriptase Inhibitor Hypersusceptibility and Resistance by Mutation of Residue 181 in HIV-1 Reverse Transcriptase. [electronic resource] by Barnard, John P Huber, Kelly D Sluis-Cremer, Nicolas Producer: 20200608 In: Antimicrobial agents and chemotherapy vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	103.	Quantification of rilpivirine in human plasma, cervicovaginal fluid, rectal fluid and genital/rectal mucosal tissues using liquid chromatography-tandem mass spectrometry. [electronic resource] by Else, Laura J Tjia, John Jackson, Akil Penchala, Sujan Dilly Egan, Deirdre Boffito, Marta Khoo, Saye H Back, David J Producer: 20150518 In: Bioanalysis vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	104.	Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort study. [electronic resource] by Gazaignes, Sandrine Resche-Rigon, Matthieu Gatey, Caroline Yang, Chloe Denis, Blandine Fonsart, Julien Desseaux, Kristell Guionie, Michel Rozenbaum, Willy Delaugerre, Constance Molina, Jean-Michel Producer: 20180119 In: Antiviral therapy vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	105.	A review of rilpivirine and elvitegravir resistance features and implications for treatment sequencing. [electronic resource] by Bourgeois, Amber Womack, Samantha Newsom, Dan Caldwell, David Producer: 20130102 In: HIV clinician vol. 24 Availability: No items available. Save to lists Add to cart (remove)
	106.	Prevalence of TMC278 (rilpivirine) associated mutations in the Frankfurt Resistance Database. [electronic resource] by Reinheimer, Claudia Doerr, Hans W Stürmer, Martin Producer: 20120830 In: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	107.	Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial. [electronic resource] by Brunetta, Jason Moreno Guillén, Santiago Antinori, Andrea Yeni, Patrick Wade, Barbara Johnson, Margaret Shalit, Peter Ebrahimi, Ramin Johnson, Bethsheba Walker, Ivan De-Oertel, Shampa Producer: 20160906 In: The patient vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	108.	Negative Regulation of Human Pregnane X Receptor by MicroRNA-18a-5p: Evidence for Suppression of MicroRNA-18a-5p Expression by Rifampin and Rilpivirine. [electronic resource] by Sharma, Devinder Turkistani, Abdullah A Chang, Wenjun Hu, Catherine Xu, Zhaoming Chang, Thomas K H Producer: 20170614 In: Molecular pharmacology vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	109.	Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus. [electronic resource] by Liu, Na Wei, Lei Huang, Li Yu, Fei Zheng, Weifan Qin, Bingjie Zhu, Dong-Qin Morris-Natschke, Susan L Jiang, Shibo Chen, Chin-Ho Lee, Kuo-Hsiung Xie, Lan Producer: 20170718 In: Journal of medicinal chemistry vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	110.	Creation of a long-acting rilpivirine prodrug nanoformulation. [electronic resource] by Hilaire, James R Bade, Aditya N Sillman, Brady Gautam, Nagsen Herskovitz, Jonathan Dyavar Shetty, Bhagya Laxmi Wojtkiewicz, Melinda S Szlachetka, Adam Lamberty, Benjamin G Sravanam, Sruthi Fox, Howard S Alnouti, Yazen Dash, Prasanta K McMillan, JoEllyn M Edagwa, Benson J Gendelman, Howard E Producer: 20201021 In: Journal of controlled release : official journal of the Controlled Release Society vol. 311-312 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	111.	Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report. [electronic resource] by Nguyen, Liem Binh Luong Harent, Stanislas Peytavin, Gilles Visseaux, Benoit Bastard, Jean P Dubourg, Odile Lariven, Sylvie Yazdanpanah, Yazdan Lescure, Francois X Producer: 20150601 In: AIDS (London, England) vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	112.	Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK. [electronic resource] by Rajoli, Rajith K R Flexner, Charles Chiong, Justin Owen, Andrew Donnelly, Ryan F Larrañeta, Eneko Siccardi, Marco Producer: 20191126 In: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V vol. 144 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	113.	Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat. [electronic resource] by Galizzi, Nadia Galli, Laura Poli, Andrea Spagnuolo, Vincenzo Castagna, Antonella Gianotti, Nicola Producer: 20190411 In: The new microbiologica vol. 41 Availability: No items available. Save to lists Add to cart (remove)
	114.	Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data. [electronic resource] by Sweeney, Zachary K Klumpp, Klaus Producer: 20080821 In: Current opinion in drug discovery & development vol. 11 Availability: No items available. Save to lists Add to cart (remove)
	115.	Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland. [electronic resource] by Parczewski, Miłosz Urbańska, Anna Maciejewska, Katarzyna Witak-Jȩdra, Magdalena Leszczyszyn-Pynka, Magdalena Producer: 20140926 In: Journal of the International AIDS Society vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	116.	E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settings. [electronic resource] by Sluis-Cremer, Nicolas Jordan, Michael R Huber, Kelly Wallis, Carole L Bertagnolio, Silvia Mellors, John W Parkin, Neil T Harrigan, P Richard Producer: 20150123 In: Antiviral research vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	117.	Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study. [electronic resource] by Porter, Danielle P Toma, Jonathan Tan, Yuping Solberg, Owen Cai, Suqin Kulkarni, Rima Andreatta, Kristen Lie, Yolanda Chuck, Susan K Palella, Frank Miller, Michael D White, Kirsten L Producer: 20160609 In: HIV clinical trials vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	118.	Switch to rilpivirine improves diabetes in an elderly HIV-positive patient. [electronic resource] by Ucciferri, Claudio Di Rosa, Zaira Vignale, Francesca Vecchiet, Jacopo Falasca, Katia Producer: 20191122 In: Le infezioni in medicina vol. 27 Availability: No items available. Save to lists Add to cart (remove)
	119.	Pre-existing mutations in the rilpivirine Phase III trials ECHO and THRIVE: prevalence and impact on virological response. [electronic resource] by Vingerhoets, Johan Rimsky, Laurence Van Eygen, Veerle Nijs, Steven Vanveggel, Simon Boven, Katia Picchio, Gaston Producer: 20130913 In: Antiviral therapy vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	120.	Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV. [electronic resource] by Turley, Sarah Lynn Fulco, Patricia Pecora Producer: 20171211 In: Journal of the International Association of Providers of AIDS Care vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 387 results.